Cargando…
Subcutaneous implants for long-acting drug therapy in laboratory animals may generate unintended drug reservoirs
BACKGROUND: Long-acting therapy in laboratory animals offers advantages over the current practice of 2-3 daily drug injections. Yet little is known about the disintegration of biodegradable drug implants in rodents. OBJECTIVE: Compare bioavailability of buprenorphine with the biodegradation of lipid...
Autores principales: | Guarnieri, Michael, Tyler, Betty M., DeTolla, Louis, Zhao, Ming, Kobrin, Barry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895292/ https://www.ncbi.nlm.nih.gov/pubmed/24459402 http://dx.doi.org/10.4103/0975-7406.124315 |
Ejemplares similares
-
Subcutaneous Implants of Buprenorphine-Cholesterol-Triglyceride Powder in Mice
por: DeTolla, L., et al.
Publicado: (2014) -
Suspected Lonely Mouse Syndrome as a Cage Effect in a Drug Safety Study
por: Ye, Xiaobu, et al.
Publicado: (2018) -
Subcutaneous Implants of a Cholesterol-Triglyceride-Buprenorphine Suspension in Rats
por: Guarnieri, M., et al.
Publicado: (2017) -
Thermal latency studies in opiate-treated mice
por: Schildhaus, Noam, et al.
Publicado: (2014) -
Long-Acting Opioid Analgesics for Acute Pain: Pharmacokinetic Evidence Reviewed
por: Tyler, Betty M., et al.
Publicado: (2023)